FDA Import Refusal BUU-1528343-1/21/1 — Zhejiang Huahai Pharmaceutical Co., Ltd.
The FDA refused shipment BUU-1528343-1/21/1 from Zhejiang Huahai Pharmaceutical Co., Ltd. (China) on February 27, 2023. The refused product falls under Drugs and Biologics — LEVETIRACETAM (ANTI-CONVULSANT). Cited charge: 115 This firm has 1 other import refusal on record.
Refusal Details
- Date
- February 27, 2023
- Country
- China
- Product Category
- Drugs and Biologics
- Product Code
- 61MCB42 LEVETIRACETAM (ANTI-CONVULSANT)
- Charges
- 115